BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"Md Faruque Pathan"”

21+ results

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Verified

Sanjay Kalra, AH Aamir, Abbas Raza, AK Das et al.

Journal: Indian Journal of Endocrinology and MetabolismYear: 2015Citations: 107

Since their introduction in clinical practice in the 1950's, Sulfonylureas (SUs) have remained the main-stay of pharmacotherapy in the management of type 2 diabetes. Despite their well-established benefits, their place in therapy is inappropriately being overshadowed by newer therapies. Many of the ...

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

Diabetes and Anemia: International Diabetes Federation (IDF) – Southeast Asian Region (SEAR) position statement

Verified

Manisha Sahay, Sanjay Kalra, Rajesh Badani, Ganapathi Bantwal et al.

Journal: Diabetes & Metabolic Syndrome Clinical Research & ReviewsYear: 2017Citations: 81

Anemia is often associated with diabetes mellitus and is known to intensify the risk of developing diabetes-related microvascular and macrovascular complications. There is paucity in understanding of co-existence of these conditions, especially in Southeast Asian countries. Iron and/or erythropoieti...

Health SciencesMedicineHematology
Read Source

Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South Asian Women With Recent Gestational Diabetes

Verified

Nikhil Tandon, Yashdeep Gupta, Deksha Kapoor, Josyula K. Lakshmi et al.

Journal: JAMA Network OpenYear: 2022Citations: 68

Importance: Women with recent gestational diabetes (GDM) have increased risk of developing type 2 diabetes. Objective: To investigate whether a resource-appropriate and context-appropriate lifestyle intervention could prevent glycemic deterioration among women with recent GDM in South Asia. Design, ...

Health SciencesMedicineObstetrics and GynecologyOpen Access
Read Source

The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the <scp>VIRTUE</scp> study

Verified

Monira Alarouj, Ahmed Hassoun, R. Medlej, Md Faruque Pathan et al.

Journal: International Journal of Clinical PracticeYear: 2013Citations: 67

AIMS: To assess, in a real-world setting, the effect of vildagliptin compared with sulphonylurea (SU) treatment on hypoglycaemia in Muslim patients with type 2 diabetes mellitus (T2DM) fasting during Ramadan. METHODS: This multinational, non-interventional study, conducted in Asia and the Middle Eas...

Health SciencesMedicinePhysiologyOpen Access
Read Source

Assessment of quality of life and its determinants in type-2 diabetes patients using the WHOQOL-BREF instrument in Bangladesh

Verified

Mohammod Feroz Amin, Bishwajit Bhowmik, Rozana Rouf, Monami Islam Khan et al.

Journal: BMC Endocrine DisordersYear: 2022Citations: 56

BACKGROUND: Diabetes mellitus (DM) is rising at a rapid rate worldwide. As a chronic, incurable metabolic disease, diabetes affects a person's life in all ways. Studies thus far have focused on the impact of diabetes on the physical and mental health of persons affected by the quality of life (QoL)....

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

Diabetic emergencies including hypoglycemia during Ramadan

Verified

Jamal Ahmad, Md Faruque Pathan, MohammedAbdul Jaleel, FarahNaaz Fathima et al.

Journal: Indian Journal of Endocrinology and MetabolismYear: 2012Citations: 50

Majority of physicians are of the opinion that Ramadan fasting is acceptable for well-balanced type 2 patients conscious of their disease and compliant with their diet and drug intake. Fasting during Ramadan for patients with diabetes carries a risk of an assortment of complications. Islamic rules a...

Health SciencesMedicinePhysiologyOpen Access
Read Source

South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan

Verified

Md Faruque Pathan, Rakesh Sahay, AbdulHamid Zarġar, SyedAbbas Raza et al.

Journal: Indian Journal of Endocrinology and MetabolismYear: 2012Citations: 41

A person with diabetes mellitus (DM) has every right to perform the ritual of fasting during Ramadan. In daily practice we come across both type 1 and type 2 DM who wish to fast. This Consensus Statement describes the pre-Ramadan assessment, planning, prescription, management, and monitoring of pati...

Health SciencesMedicinePhysiologyOpen Access
Read Source

Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement

Verified

Sanjay Kalra, Sujoy Ghosh, AH Aamir, Md. Tofail Ahmed et al.

Journal: Indian Journal of Endocrinology and MetabolismYear: 2016Citations: 25

Diabetes prevalence shows a continuous increasing trend in South Asia. Although well-established treatment modalities exist for type 2 diabetes mellitus (T2DM) management, they are limited by their side effect profile. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) with their novel insulin-inde...

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

Intestinal alkaline phosphatase deficiency increases the risk of diabetes

Verified

Jagannath Malo, Md. Jahangir Alam, Salequl Islam, Md. Abdul Mottalib et al.

Journal: BMJ Open Diabetes Research & CareYear: 2022Citations: 17

Introduction Our previous case–control study demonstrated that a high level of intestinal alkaline phosphatase (IAP), an endotoxin-detoxifying anti-inflammatory enzyme secreted by villus-associated enterocytes and excreted with stool, plays a protective role against type 2 diabetes mellitus (T2DM) i...

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

The challenge of proper glycaemic control among patients with type 2 diabetes in Bangladesh

Verified

Shahjada Selim, Faruque Pathan, Mohammad Saifuddin, Z. A. Latif et al.

Journal: Sri Lanka Journal of Diabetes Endocrinology and MetabolismYear: 2016Citations: 17

Official Journal of the Endocrine Society of Sri Lanka. The Sri Lanka Journal of Diabetes Endocrinology and Metabolism (SJDEM) publishes original research articles, reviews, and other special features related to diabetes, endocrinology and metabolism in humans and human tissue.

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

Thyroid diseases and Ramadan

Verified

Syeda Zareen Raza, Osama Ishtiaq, AG Unnikrishnan, AK Azad Khan et al.

Journal: Indian Journal of Endocrinology and MetabolismYear: 2012Citations: 17

In the month of Ramadan, patients with thyroid diseases, most of the time, do not need treatment adjustments and can fast safely without any health hazards. Patients with hypothyroidism taking thyroxine can take their tablets on an empty stomach at bedtime instead of half an hour before Sehr. Patien...

Health SciencesMedicinePhysiologyOpen Access
Read Source

Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh

Verified

Md Faruque Pathan, Nazma Akter, Shahjada Selim, Mohammad Saifuddin et al.

Journal: Diabetes Metabolic Syndrome and ObesityYear: 2022Citations: 15

Aim: In Bangladesh, there is a large population of Muslims with type 2 diabetes mellitus (T2DM) who fast during Ramadan. Changes in the pattern of meal and fluid intake during this long-fasting hours may increase the risk of hypoglycaemia, hyperglycaemia, and dehydration. Our key point of focus was ...

Health SciencesMedicinePhysiologyOpen Access
Read Source

South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan

Verified

Md Faruque Pathan, Rakesh Sahay, AbdulHamid Zarġar, SyedAbbas Raza et al.

Journal: Indian Journal of Endocrinology and MetabolismYear: 2012Citations: 15

Ramadan is a lunar based month, during which Muslims across the world observe the ritual fast. This provides a challenge not only to the diabetic patient who wishes to observe the fast but also to the health care professional managing his diabetes. The challenge is to use therapies which are effecti...

Health SciencesMedicinePhysiologyOpen Access
Read Source

Biosimilar insulins: Informed choice for South Asia

Verified

Sanjay Kalra, A K Azad Khan, Syed Abbas Raza, Noel Somasundaram et al.

Journal: Indian Journal of Endocrinology and MetabolismYear: 2015Citations: 10

As diabetes has become endemic in South Asia, we, as health care professionals, have to reassess our strategy to tackle the condition. One way in which this is done is by encouraging development, and rational usage, of modern pharmaceuticals. Such drugs are expected to be effective, safe and well-to...

Health SciencesMedicinePediatrics, Perinatology and Child HealthOpen Access
Read Source

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study

Verified

Ahmed Hassoun, Md Faruque Pathan, R. Medlej, Monira Alarouj et al.

Journal: Diabetes Metabolic Syndrome and ObesityYear: 2016Citations: 9

BACKGROUND: VIRTUE was a prospective, observational study assessing the effectiveness and safety of vildagliptin vs sulfonylureas (SUs) (both as monotherapy and in combination with metformin) in patients with type 2 diabetes mellitus who fasted during Ramadan. A post hoc analysis was carried out to ...

Health SciencesMedicinePhysiologyOpen Access
Read Source

Guidelines regarding management of adrenal insufficiency in the Holy month of Ramadan

Verified

SheeluS Siddiqi, SK Singh, S. A. Khan, Osama Ishtiaq et al.

Journal: Indian Journal of Endocrinology and MetabolismYear: 2012Citations: 9

Adrenal insufficiency is a life-threatening event, so it is recommended for patients with known adrenal insufficiency to be properly educated regarding sick-day management. In the month of Ramadan, people refrain from eating and drinking during daylight hours. It is very important for patients with ...

Health SciencesMedicinePhysiologyOpen Access
Read Source

Orlistat as an adjunct therapy in type 2 obese diabetic patients treated with sulphonylurea: a Bangladesh experience.

Verified

Md Faruque Pathan, ZA Latif, Nazia Nazneen, Saima Mili

Journal: PubMedYear: 2004Citations: 9

Co-existence of obesity and type 2 DM exacerbates metabolic and other remediable health consequences further. Various pharmacological therapies have been adopted when changing of lifestyle fail to achieve target glycaemic control. Our objective is to find out whether Orlistat can reduce both weight ...

Health SciencesMedicinePharmacology
Read Source

Frequency and Predictors of Erectile Dysfunction in Bangladeshi Men with Type 2 Diabetes Mellitus: Experience from a Tertiary Center.

Verified

Mohammad Imtiaj Mahbub, A B Kamrul-Hasan, Shahjada Selim, Ahmed Salam Mir et al.

Journal: PubMedYear: 2019Citations: 6

Erectile dysfunction (ED) is a common complication of diabetes mellitus. But it is frequently under diagnosed and may result in poor quality of life. Previous studies have shown a high frequency of ED in diabetic men. The aim of this cross-sectional study was to determine the frequency of ED and exp...

Health SciencesMedicineEndocrinology, Diabetes and Metabolism
Read Source

A Case of Adrenal Histoplasmosis

Verified

Faria Afsana, Kazi Nazmul Hossain, Ashfaq Tareque, Mohammad Feroz Amin et al.

Journal: BIRDEM Medical JournalYear: 2017Citations: 6

Histoplasmosis is a fungal disease that may present as chronic pulmonary infection or in disseminated form. Disseminated histoplasmosis frequently affects the adrenal gland; sometimes adrenal gland may be the only site of demonstrable disease. Unilateral involvement in immunosuppressed patients is t...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19

Verified

Faruque Pathan, Shahjada Selim, Md Fariduddin, Md Hafizur Rahman et al.

Journal: Diabetes Metabolic Syndrome and ObesityYear: 2021Citations: 5

BACKGROUND: The year 2020 witnessed a largely unprecedented pandemic of coronavirus disease (COVID-19), caused by SARS COV-2. Many people with COVID-19 have comorbidities, including diabetes, hypertension and cardiovascular diseases, which are significantly associated with worse outcomes. Moreover, ...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source
PreviousPage 1 of 2+Next